Lingxiao Wei

Statistics

Publications

Citations

131

H-Index

Active since

2018

Affiliations

Second Affiliated Hospital of Harbin Medical University(Current)

Harbin Medical University

Lingxiao Wei is an author at Second Affiliated Hospital of Harbin Medical University specializing in molecular oncology, targeted cancer therapy, and medicine.

Publications per year

2018–2021

Publications

Efficacy and Safety of Intrathecal Pemetrexed Combined With Dexamethasone for Treating Tyrosine Kinase Inhibitor-Failed Leptomeningeal Metastases From EGFR-Mutant NSCLC—a Prospective, Open-Label, Single-Arm Phase 1/2 Clinical Trial (Unique Identifier: ChiCTR1800016615)

Chengjuan Fan, Qiuyu Zhao, Li Li et al. · Journal of Thoracic Oncology · 2021 · 98 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Comparison of efficacy and toxicity of bevacizumab, endostar and apatinib in transgenic and human lung cancer xenograftzebrafish model

Yinghua Jin, Lingxiao Wei, Qiuying Jiang et al. · Scientific Reports · 2018 · 33 citations · Full text

Medicine, Oncology, Pharmacology +16

1–2 of 2